![Colorful-brain-mind-600x465](https://medphanut.com/wp-content/uploads/2024/05/Colorful-brain-mind-600x465-600x381.jpg)
AbbVie’s alliance with Gilgamesh Pharmaceuticals is pursuing next-generation psychiatric medications. The companies aim to bring patients drugs that offer the benefit of psychedelics but with a better side effect profile.
The post AbbVie Expands Psychiatric Drug Prospects, Inking R&D Pact With Neuroscience Startup appeared first on MedCity News.